Philips Preps NeoPAP Launch To Address Premature Infants’ Developmental Needs
This article was originally published in The Gray Sheet
Philips Healthcare’s planned fourth-quarter launch of its NeoPAP neonatal continuous positive airway pressure device for premature infants reinforces the device maker’s philosophy of addressing not just acute episodes of care but also their long-term developmental outcomes.
You may also be interested in...
A 2007 Stanford graduate course in affordable design has paved the way to the upcoming launch of a medical device that could save the lives of 100,000 babies within five years.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.
China’s Bio-Thera Solutions has ventured outside of its domestic market for the first time by filing an application for a biosimilar version of Avastin with the European Medicines Agency. The company has also revealed its timeline for a submission to the FDA.